Who We Are

Built on Science. Driven by Purpose.

Monarch Therapeutics was founded on the belief that cancer treatment must evolve as rapidly as the disease itself — through adaptive, genomically-informed medicine.

Our Story

Monarch Therapeutics was established to address one of oncology's most persistent challenges: the inability of static treatments to keep pace with dynamic, evolving tumors.

Our founders — scientists and clinicians with decades of combined experience in genomics and oncology — set out to build a platform that could learn, adapt, and respond alongside the patient's biology.

Today, Monarch Therapeutics is advancing a pipeline of adaptive personalized medicines designed to meet each patient where they are — and evolve with them throughout their treatment journey.

Monarch Therapeutics research team

What Guides Us

Our Core Values

Scientific Rigor

Every decision we make is grounded in data, evidence, and the highest standards of translational research.

Patient Centricity

The patient is at the center of everything we do — from early discovery through clinical development.

Adaptive Thinking

We embrace complexity and uncertainty, building systems and therapies that evolve rather than remain static.

Collaborative Spirit

We partner with leading academic institutions, clinical networks, and industry partners to accelerate impact.

Join Us in Redefining Oncology

Whether you are a researcher, investor, or healthcare partner, we welcome the opportunity to connect.

Get In Touch